Jubilant Pharmova Ltd. Financials

NSE BSE

15:59 Jul 18

Jubilant Pharmova Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

1232.00

+31.20 (+2.60%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

1232.00

+31.20 (+2.60%)
15:59 Jul 18

Quality

89/100
High Financial Strength

Valuation

57/100
Affordable Valuation

Technical

57/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	6098.54	6130.16	6281.73	6702.9	7234.5
Operating Expenses +	4702.07	4973.83	5505.48	5802.1	6060.8
Raw Material	1516.38	1550.32	1918.63	2062.5	2282.4
Increase Decrease in Cost	19.63	-62.32	-40.7	78.2	34.6
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	1922.88	2043.39	2166.02	2216	2267.9
Miscellaneous Expenses	1578.44	1845.68	1965.97	1927.8	2070.1
Operating Profit	1396.47	1156.33	776.25	900.8	1173.7
Other Income	17.64	11.29	38.33	68.7	56.8
Depreciation	348.95	381.7	554.03	381.9	368.6
Interest	184.1	145.49	188.2	272.3	240.3
Profit before tax and exceptio..	881.06	640.43	72.34	315.3	621.6
Exceptional Items	-21.23	0	-56.82	-168.9	359.5
PBT	859.82	640.43	15.53	146.4	981.1
Provision for Taxation	297.22	217.43	92.66	97.8	144.3
Net Profit	824.36	423	-77.13	48.6	836.8
NET Profit after MI	835.87	413.94	-60.98	77.1	839.4
EPS	52.48	26	-3.83	4.86	52.85
Operating Profit Margin (%)	22.9	18.86	12.36	13.44	16.22
Net Profit Margin (%)	13.71	6.75	-0.97	1.15	11.6

All Data in Percentage (%)

	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24
Promoter	50.70	50.70	50.70	50.70	50.70
FII	17.20	17.00	17.90	19.50	19.10
MF	3.70	3.60	3.10	2.20	2.30
Others	3.40	3.40	2.60	1.90	1.40

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: